Arkolith/Insider Trading/CCXI/Form 4

Tyree James L

DirectorChemoCentryx, Inc. (CCXI) · full profile →Form 4 · filed Dec 21, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.3M
Net Open-Market Flow
-$1.3M
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 17, 2021Sell(S)18K$35.50$641K15K
Dec 17, 2021Sell(S)17K$34.74$578K33K
Dec 17, 2021Sell(S)3K$33.52$94K50K
Dec 17, 2021Option exercise(M)25K$12.62$316K40K
Dec 17, 2021Option exercise(M)13K$14.42$180K53K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 17, 2021Option exercise(M)25K——0
Dec 17, 2021Option exercise(M)13K——0

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-070839) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for ChemoCentryx, Inc.

Build

Ask your agent about CCXI insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001209191-21-070839"
Ask your agent
Use Arkolith to summarize insider buying and selling at ChemoCentryx, Inc.
over the last 90 days and cite the filings.